6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
ZA200801707B
IKK inhibitors for the treatment of endometriosis
WO2008090217A1
Purification of fc-tact fusion proteins using the oilbody technology
WO2008028928A1
Novel combination of agents for the treatment of hiv-associated adipose redistribution syndrome (hars)
WO2008015199A1
Chemokine antagonists
EP2041166A1
Process for globular adiponectin production
US2009176762A1
JNK Inhibitors for Treatment of Skin Diseases
CA2630928A1
Novel cc-chemokine antagonists
EP1979346A1
Thiazole derivatives and use thereof
WO2007084441A2
Novel fsh glycosylation variant d3n
ZA200804677B
FSH Mutants
US2008299072A1
Chemokine Antagonists
CA2631291A1
Antiproliferative pyrimidyl, fused pyrimidyl and pyridyl hydrazones
CA2621705A1
Erythropoietin polypeptides and uses thereof
EP1957541A2
Compositions and methods of producing hybrid antigen binding molecules and uses thereof
CA2617598A1
Use of sdf-1 for the treatment and/or prevention of neurological diseases
KR20080064880A
Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
